HEARTBURN RELIEF aluminum hydroxide and magnesium carbonate 254 mg/5mL; 237.5 mg/5mL Suspension, 355 mL — NDC 63868-0565-12 package photo

HEARTBURN RELIEF aluminum hydroxide and magnesium carbonate 254 mg/5mL; 237.5 mg/5mL Suspension, 355 mL

by CHAIN DRUG MARKETING ASSOCIATION · 355 mL in 1 BOTTLE (63868-565-12)
NDC 63868-0565-12
🏷️ FDA NDC (as labeled) 63868-565-12 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 63868-565-12
Product NDC 63868-565
11-digit billing NDC 63868056512
RxCUI 245001
UNII 5QB0T2IUN0, 0E53J927NA
Application # M001
SPL Set ID b4656a2f-a866-5f7a-e053-2995a90ac2c2
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-11-01
Route ORAL
Dosage form SUSPENSION
Substance ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE
Why two NDCs? The FDA registers this code as 63868-565-12 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 63868-0565-12. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Drugs for treatment of hyperkalemia and hyperphosphatemia class.

Drug family (ATC) Drugs for treatment of hyperkalemia and hyperphosphatemia, Magnesium compounds, Osmotically acting laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerCHAIN DRUG MARKETING ASSOCIATION
FDA applicationM001 (OTC MONOGRAPH DRUG)
Labeler code63868
First marketedNov 2019
Product typeHuman Otc Drug
Portfolio128 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is an over-the-counter oral suspension marketed under FDA's OTC monograph rules for heartburn relief. It contains two antacid ingredients, aluminum hydroxide and magnesium carbonate, which are typically used to neutralize stomach acid and help ease discomfort from heartburn and indigestion. The liquid suspension form allows for easy swallowing and faster absorption compared to tablets.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Extra Strength Heartburn Relief 254 mg/5mL; 237.5 mg/5mL 70000-0363-01 CARDINAL 355 ml $0.015 Availability likely
Gaviscon 254 mg/5mL; 237.5 mg/5mL 00135-0095-41 Haleon 355 ml FDA listed
Gaviscon 254 mg/5mL; 237.5 mg/5mL 00135-0574-01 Haleon 355 ml FDA listed
Walgreens Fast Acting Heartburn Relief Extra Strength 254 mg/5mL; 237.5 mg/5mL 00363-7630-12 WALGREEN 355 ml FDA listed
HEB Extra Strength Cool Mint 254 mg/5mL; 237.5 mg/5mL 37808-0632-12 HEB 355 ml FDA listed
Heartburn Relief 254 mg/5mL; 237.5 mg/5mL 57896-0565-12 GERI-CARE 355 ml FDA listed
Heartburn Relief 254 mg/5mL; 237.5 mg/5mLthis 63868-0565-12 CHAIN 355 ml FDA listed
CVS Health Extra Strength Antacid 254 mg/5mL; 237.5 mg/5mL 69842-0376-12 CVS 355 ml FDA listed
Extra Strength Heartburn Relief 254 mg/5mL; 237.5 mg/5mL 69842-0628-12 CVS 355 ml FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Nov 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Heartburn Relief (this brand).

Top reported reactions

Nausea5,340
Fatigue5,117
Diarrhoea4,889
Chronic Kidney Disease4,010
Dyspnoea3,945
Headache3,566
Vomiting3,314

Age at onset

Neonate54
Infant134
Child456
Adolescent325
Adult9,075
Elderly7,568

Reporter sex

81,733 reports
Male · 39%
Female · 61%
Unknown · 0%

Serious outcomes

Hospitalization28,687
Death8,292
Life-threatening4,587
Disabling1,902
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 9,406 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
63868-0565-12 You're viewing this 355 mL in 1 BOTTLE (63868-565-12) 2019-11-01 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 63868-565-12, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 63868-0565-12, written without dashes as 63868056512. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 63868-0565-12, the first segment (63868) is the labeler code FDA assigned to CHAIN DRUG MARKETING ASSOCIATION; the middle segment (0565) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (12) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by CHAIN DRUG MARKETING ASSOCIATION. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
CHAIN DRUG MARKETING ASSOCIATION is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 13 words

Uses relieves heartburn sour stomach acid indigestion upset stomach associated with these symptoms

⏱️ Dosage and Administration 47 words

Directions shake well before use adults and children 12 years and older take 2-4 teaspoonsful four times a day or as directed by a doctor children under 12 years: consult a doctor take after meals and at bedtime dispense product only by spoon or other measuring device

⚠️ Warnings 98 words

Warnings Ask a doctor before use if you have kidney disease a magnesium-restricted diet a sodium-restricted diet Ask a doctor or pharmacist before use if you are taking a prescription drug. Antacids may interact with certain prescription drugs. When using this product laxative effect may occur do not use maximum dosage for more than 2 weeks do not take more than 16 teaspoonfuls in 24 hours If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📦 Storage and Handling 43 words

Other information each 5 mL teaspoonful contains: magnesium 70 mg, sodium 16 mg store at room temperature protect from freezing keep tightly closed TAMPER-EVIDENT : Do not use this product if inner foil seal over mouth of the bottle is broken or missing.

🧪 Active Ingredient 15 words

Active ingredients (in each 5 mL teaspoonful) Aluminum hydroxide 254 mg Magnesium carbonate 237.5 mg

🧪 Inactive Ingredients 20 words

Inactive ingredients benzyl alcohol, edetate disodium, flavor, glycerin, purified water, saccharin sodium, simethicone emulsion, sodium alginate, sorbitol solution, xanthan gum

🎯 Purpose 2 words

Purpose Antacid

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.